Table of Contents
International Journal of Molecular Imaging
Volume 2016, Article ID 8434308, 9 pages
http://dx.doi.org/10.1155/2016/8434308
Research Article

Visualization of Inflammation at Early Stage of Lung Cancer in Xenografted Temporally Immunosuppression Rats by Ferrioxamine Magnetic Resonance Imaging

1Laboratory of Physical Chemistry, Molecular, and Cellular Biology, Center of Excellence for Molecular Imaging, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, 50200, Thailand
2Clinical Investigation Center of Besançon, Inserm CICB 1431, University Hospital of Besançon, 2, Place St. Jacques, 25030 Besançon, France
3Cutaneous Engineering and Biology Team, Inserm UMR 1098, University of Bourgogne Franche-Comté, 19 rue Ambroise Paré, Besançon, France
4Department of Structural Biology and Bioenergetics Mechanisms, Commission for Atomic Energy, Institute of Biology and Technologies-Saclay, 91191 Gif-sur-Yvette, France

Received 17 May 2016; Accepted 26 September 2016

Academic Editor: J. M. Mountz

Copyright © 2016 Nathupakorn Dechsupa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Howard, H. Chu, B. E. Zeligman et al., “Irradiated nude rat model for orthotopic human lung cancers,” Cancer Research, vol. 51, no. 12, pp. 3274–3280, 1991. View at Google Scholar · View at Scopus
  2. J. Hoogenhout, I. Kazem, C. R. Jerusalem et al., “Tumor xenotransplantation in Wistar rats after treatment with cyclophosphamide and total lymphoid irradiation,” Radiology, vol. 145, no. 1, pp. 191–194, 1982. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Akhter, P. Yao, L. A. Johnson, S. M. Riordan, and D. L. Morris, “A new peritoneal carcinomatosis model in cyclosporine immunosuppressed rats,” Anticancer Research, vol. 28, no. 1, pp. 105–108, 2008. View at Google Scholar · View at Scopus
  4. J. Hoogenhout, I. Kazem, C. R. Jerusalem et al., “Growth pattern of tumor xenografts in wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin A,” International Journal of Radiation Oncology, Biology, Physics, vol. 9, no. 6, pp. 871–879, 1983. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Dechsupa, S. Kothan, and J. Vergote, “Quercetin, Siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo,” Cancer Biology & Therapy, vol. 6, no. 1, pp. 56–61, 2007. View at Publisher · View at Google Scholar
  6. M. Kaartinen, M. Eray, E. Lehtonen, A. Matoso-Ferreira, and J. Tienari, “Implanted solid human tumours grow under the renal capsule of cyclosporin-immunosuppressed rats,” Scandinavian Journal of Immunology, vol. 39, no. 6, pp. 618–624, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Flechner, “cyclosporine: a new and promising immunosuppressive agent,” The Urologic Clinics of North America, vol. 10, no. 2, pp. 263–275, 1983. View at Google Scholar · View at Scopus
  8. A. D. Hess, L. Horwitz, W. E. Beschorner, and G. W. Santos, “Development of graft-vs-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity,” Journal of Experimental Medicine, vol. 161, no. 4, pp. 718–730, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kawahara, S. Murakami, Y. Noiri et al., “Effects of cyclosporin-A-induced immunosuppression on periapical lesions in rats,” Journal of Dental Research, vol. 83, no. 9, pp. 683–687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Goodman, J. L. McCullough, C. A. Bircn, and R. J. Barr, “A model of human melanoma in cyclosporine-immunosuppressed rats,” The Journal of Investigative Dermatology, vol. 88, no. 2, pp. 141–144, 1987. View at Google Scholar
  11. D. J. Bernard, J.-C. Maurizis, J. Chassagne et al., “Effects of cyclosporine A on Ia antigen expression in N-nitroso-N-methylurea-induced rat mammary tumors,” Cancer Research, vol. 50, no. 11, pp. 3301–3305, 1990. View at Google Scholar · View at Scopus
  12. T. Mathiesen, V. P. Collins, L. Olson, and L. Granholm, “Prolonged survival and vascularization of xenografted human glioblastoma cells in the central nervous system of Cyclosporine A treated rats,” Cancer Letters, vol. 44, no. 2, pp. 151–156, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Nagy, J. W. Eaton, V. Jeney et al., “Red cells, hemoglobin, heme, iron, and atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 7, pp. 1347–1353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Taketani, “Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation,” Tohoku Journal of Experimental Medicine, vol. 205, no. 4, pp. 297–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, “Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability,” Carcinogenesis, vol. 30, no. 7, pp. 1073–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Roma-Rodrigues, A. R. Fernandes, and P. V. Baptista, “Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells,” BioMed Research International, vol. 2014, Article ID 179486, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Rahat and J. Shakya, “Parallel aspects of the microenvironment in cancer and autoimmune disease,” Mediators of Inflammation, vol. 2016, Article ID 4375120, 17 pages, 2016. View at Publisher · View at Google Scholar
  18. J. L. Martin-Ventura, J. Madrigal-Matute, R. Martinez-Pinna et al., “Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options,” Thrombosis and Haemostasis, vol. 108, no. 3, pp. 435–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Wu and B. P. Zhou, “Inflammation: a driving force speeds cancer metastasis,” Cell Cycle, vol. 8, no. 20, pp. 3267–3273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Udom-Uttaracheva, Cellular characterization of ferric-desferoxamine complex and its biodistribution in Wistar rats by MR-imaging [M.S. thesis of Medical Radiation Science], Chiang Mai University, Chiang Mai, Thailand, 2008.
  21. N. Lu, L. Yi, Q. Deng, J. Li, Z. Gao, and H. Li, “The interaction between desferrioxamine and hemin: a potential toxicological implication,” Toxicology in Vitro, vol. 26, no. 5, pp. 732–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Sibmooh, R. Udomsangpetch, A. Kijjoa, U. Chantharaksri, and S. Mankhetkorn, “Redox reaction of artemisinin with ferrous and ferric ions in aqueous buffer,” Chemical and Pharmaceutical Bulletin, vol. 49, no. 12, pp. 1541–1546, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Mankhetkorn, Z. Abedinzadeh, and C. Houee-Levin, “Antioxidant action of sodium diethyldithiocarbamate: reaction with hydrogen peroxide and superoxide radical,” Free Radical Biology and Medicine, vol. 17, no. 6, pp. 517–527, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. K. L. Li, X. P. Zhu, D. R. Checkley et al., “Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data,” British Journal of Radiology, vol. 76, no. 901, pp. 39–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Buckley and G. J. M. Parker, “Measuring contrast agent concentration in T1-weighted dynamic contrast-enhanced MRI,” in Dynamic Contrast Enhancement Techniques in Oncology, A. Jackson, D. L. Buckley, and G. J. M. Parker, Eds., vol. 80, pp. 69–80, Springer, 2004. View at Google Scholar
  26. P. Allain, Y. Mauras, D. Chaleil et al., “Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis,” British Journal of Clinical Pharmacology, vol. 24, no. 2, pp. 207–212, 1987. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Verpooten, P. C. D'Haese, J. R. Boelaert, I. Becaus, L. V. Lamberts, and M. E. De Broe, “Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 7, no. 9, pp. 931–938, 1992. View at Google Scholar · View at Scopus